This week, we want to help you simplify your selection of injectables for patients. While most patients often think that an injection is always insulin, we know that is not true. We also have GLP-1 analogs, as well as combinations of these products, so in our Homerun Slides, we make …

So many of my patients who have insulin resistance, type 1 or type 2 diabetes with hyperglycemia and/or obesity have vitamin D or vitamin B12 deficiency. Often they have never had their levels checked or, if they have, were diagnosed with either or both vitamin D deficiency and vitamin B12 deficiency and do not take their prescribed vitamins. Why?

In part 5 of this Exclusive Interview, Dr. Aaron Vinik talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about the need to continue research into drugs such as SGLT-2s because breakthroughs may possibly be found in these medications.

In this week's Homerun Slides, medication trial results, long-acting insulins, and treating prediabetes.

Hypertriglyceridemia and low HDL cholesterol, increased risk of type 2 diabetes: Under fasting conditions, the liver of subjects with NAFLD overproduces triglyceride-enriched VLDL particles despite hyperinsulinemia when compared to equally obese subjects without NAFLD. Insulin normally decreases production of VLDL by inhibiting adipose tissue lipolysis, and by directly suppressing hepatic production of VLDL.